KB-R7785

KB-R7785

Cat. No.: DIA-0243295

Size: 50 mg Size: 100 mg Size: 250 mg Size: Customer Size
Product Information
CAS No. 168158-16-5
Formula C18H27N3O4
Molecular Weight 349.42
SMILES ONC([C@@H](C)[C@@H](CC(C)C)C(N[C@@H](C1=CC=CC=C1)C(NC)=O)=O)=O
Target MMP
Product Description KB-R7785 is a novel matrix metalloproteinase (MMP) inhibitor, which improves insulin sensitivity by inhibiting TNF-α production. KB-R7785 can be used for diabetes research. KB-R7785 has a protective efficacy against focal cerebral ischemia.
Format & Storage
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top